# OnCo record paper-cheng-melanoma-ctdna-antiparasitic-front-oncol-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cheng-melanoma-ctdna-antiparasitic-front-oncol-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cheng-melanoma-ctdna-antiparasitic-front-oncol-2026" ;
  schema:name "Metastatic melanoma with initial ctDNA decline and radiographic response during self-directed antiparasitic use: treatment effect or spontaneous regression?"@en ;
  schema:description "A man with metastatic melanoma who refused standard treatment and took ivermectin and fenbendazole saw his tumour markers and scans improve for a while, then worsen; his oncologists judged spontaneous immune regression at least as likely as any drug effect."@en ;
  schema:url <https://onco.cc/key-papers/paper-cheng-melanoma-ctdna-antiparasitic-front-oncol-2026/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.3389/fonc.2026.1907192>, <https://pubmed.ncbi.nlm.nih.gov/42745863/> ;
  schema:sameAs <https://doi.org/10.3389/fonc.2026.1907192> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Cheng R, Araujo DV." ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/fenbendazole-ivermectin-repurposing-claims/> ;
  onco:drugs <https://onco.cc/drugs/ivermectin/>, <https://onco.cc/drugs/fenbendazole/> .